217 related articles for article (PubMed ID: 29999001)
21. Ginsenoside Rg1 inhibits angiotensin II-induced podocyte autophagy via AMPK/mTOR/PI3K pathway.
Mao N; Tan RZ; Wang SQ; Wei C; Shi XL; Fan JM; Wang L
Cell Biol Int; 2016 Aug; 40(8):917-25. PubMed ID: 27296076
[TBL] [Abstract][Full Text] [Related]
22. Heme oxygenase-1 enhances autophagy in podocytes as a protective mechanism against high glucose-induced apoptosis.
Dong C; Zheng H; Huang S; You N; Xu J; Ye X; Zhu Q; Feng Y; You Q; Miao H; Ding D; Lu Y
Exp Cell Res; 2015 Oct; 337(2):146-59. PubMed ID: 25882498
[TBL] [Abstract][Full Text] [Related]
23. HGF alleviates high glucose-induced injury in podocytes by GSK3β inhibition and autophagy restoration.
Zhang C; Hou B; Yu S; Chen Q; Zhang N; Li H
Biochim Biophys Acta; 2016 Nov; 1863(11):2690-2699. PubMed ID: 27526674
[TBL] [Abstract][Full Text] [Related]
24. Emodin Ameliorates High Glucose-Induced Podocyte Apoptosis via Regulating AMPK/mTOR-Mediated Autophagy Signaling Pathway.
Liu H; Chen WD; Hu YL; Yang WQ; Hu TT; Wang HL; Zhang YM
Chin J Integr Med; 2023 Sep; 29(9):801-808. PubMed ID: 36219383
[TBL] [Abstract][Full Text] [Related]
25. The novel involvement of podocyte autophagic activity in the pathogenesis of lupus nephritis.
Jin J; Ye M; Zhao L; Zou W; Shen W; Zhang H; Gong J; He Q
Histol Histopathol; 2018 Aug; 33(8):803-814. PubMed ID: 29446059
[TBL] [Abstract][Full Text] [Related]
26. Tripterygium glycoside protects against puromycin amino nucleoside‑induced podocyte injury by upregulating autophagy.
Gong J; Jin J; Zhao L; Li Y; Li Y; He Q
Int J Mol Med; 2018 Jul; 42(1):115-122. PubMed ID: 29620171
[TBL] [Abstract][Full Text] [Related]
27. Glucagon-like peptide-1 analog prevents obesity-related glomerulopathy by inhibiting excessive autophagy in podocytes.
Guo H; Wang B; Li H; Ling L; Niu J; Gu Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F181-F189. PubMed ID: 29070572
[TBL] [Abstract][Full Text] [Related]
28. LncRNA Hoxb3os protects podocytes from high glucose-induced cell injury through autophagy dependent on the Akt-mTOR signaling pathway.
Jin J; Gong J; Zhao L; Li Y; He Q
Acta Biochim Pol; 2021 Oct; 68(4):619-625. PubMed ID: 34648253
[TBL] [Abstract][Full Text] [Related]
29. Lipopolysaccharide-induced podocyte injury is mediated by suppression of autophagy.
Tan X; Chen Y; Liang X; Yu C; Lai Y; Zhang L; Zhao X; Zhang H; Lin T; Li R; Shi W
Mol Med Rep; 2016 Jul; 14(1):811-8. PubMed ID: 27221629
[TBL] [Abstract][Full Text] [Related]
30. Krüppel‑like factor 4 ameliorates diabetic kidney disease by activating autophagy via the mTOR pathway.
Gong J; Zhan H; Li Y; Zhang W; Jin J; He Q
Mol Med Rep; 2019 Oct; 20(4):3240-3248. PubMed ID: 31432191
[TBL] [Abstract][Full Text] [Related]
31. Atrasentan alleviates high glucose-induced podocyte injury by the microRNA-21/forkhead box O1 axis.
Wang J; Shen L; Hong H; Li J; Wang H; Li X
Eur J Pharmacol; 2019 Jun; 852():142-150. PubMed ID: 30876973
[TBL] [Abstract][Full Text] [Related]
32. P2X7R/AKT/mTOR signaling mediates high glucose-induced decrease in podocyte autophagy.
Qian C; Lu J; Che X; Min L; Wang M; Song A; Lu R; Gu L; Xie K
Free Radic Biol Med; 2023 Aug; 204():337-346. PubMed ID: 37245531
[TBL] [Abstract][Full Text] [Related]
33. Celastrol antagonizes high glucose-evoked podocyte injury, inflammation and insulin resistance by restoring the HO-1-mediated autophagy pathway.
Zhan X; Yan C; Chen Y; Wei X; Xiao J; Deng L; Yang Y; Qiu P; Chen Q
Mol Immunol; 2018 Dec; 104():61-68. PubMed ID: 30439604
[TBL] [Abstract][Full Text] [Related]
34. Tripterygium glycoside suppresses epithelial‑to‑mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway.
Tao M; Zheng D; Liang X; Wu D; Hu K; Jin J; He Q
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165172
[TBL] [Abstract][Full Text] [Related]
35. Silencing of PFKFB3 protects podocytes against high glucose‑induced injury by inducing autophagy.
Zhu Z; Liu Q; Sun J; Bao Z; Wang W
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34490476
[TBL] [Abstract][Full Text] [Related]
36. High Glucose-Induced Podocyte Injury Involves Activation of Mammalian Target of Rapamycin (mTOR)-Induced Endoplasmic Reticulum (ER) Stress.
Lei J; Zhao L; Zhang Y; Wu Y; Liu Y
Cell Physiol Biochem; 2018; 45(6):2431-2443. PubMed ID: 29554648
[TBL] [Abstract][Full Text] [Related]
37. Shensu IV prevents glomerular podocyte injury in nephrotic rats via promoting lncRNA H19/DIRAS3-mediated autophagy.
Huang Y; Huang Y; Zhou Y; Cheng J; Wan C; Wang M; Pi C; Wu G; Song W
Biosci Rep; 2021 May; 41(5):. PubMed ID: 33881140
[TBL] [Abstract][Full Text] [Related]
38. Hispidulin alleviates high-glucose-induced podocyte injury by regulating protective autophagy.
Wu F; Li S; Zhang N; Huang W; Li X; Wang M; Bai D; Han B
Biomed Pharmacother; 2018 Aug; 104():307-314. PubMed ID: 29775899
[TBL] [Abstract][Full Text] [Related]
39. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
[TBL] [Abstract][Full Text] [Related]
40. SPAG5-AS1 inhibited autophagy and aggravated apoptosis of podocytes via SPAG5/AKT/mTOR pathway.
Xu J; Deng Y; Wang Y; Sun X; Chen S; Fu G
Cell Prolif; 2020 Feb; 53(2):e12738. PubMed ID: 31957155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
